Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy
Nanoscale · 2023
DOI: 10.1039/d2nr07071e ↗At a glance
Übersichtsarbeit in Nanoscale, 2023. Written by Lingyang Meng and 6 co-authors. Institution: College of Marine Life Science, Ocean University of China, Qingdao, 266003, P.R. China. yaliu@ouc.edu.cn. Major MEDLINE topics: Neoplasms, Nanoparticles, Cancer Vaccines. Cited 28 times so far (Crossref); 175 references. Funded by: Natural Science Foundation of Shandong Province.
Abstract (original language)
The incorporation of biomimetic nanoparticles into the DC vaccination strategies has shown outstanding advantages in precisely directing the immune system to fight cancer.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- College of Marine Life Science, Ocean University of China, Qingdao, 266003, P.R. China. yaliu@ouc.edu.cn.
- Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266000, P.R. China.
Funding
- Natural Science Foundation of Shandong Province
Cite
APA
Meng, L., Teng, Z., Yang, S., Wang, N., Guan, Y., Chen, X., & Liu, Y. (2023). Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy. Nanoscale. https://doi.org/10.1039/d2nr07071e
Vancouver
Meng L, Teng Z, Yang S, Wang N, Guan Y, Chen X, et al. Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy. Nanoscale. 2023. doi:10.1039/d2nr07071e
BibTeX
@article{Meng2023,
author = {Meng, Lingyang and Teng, Zhuang and Yang, Shuang and Wang, Na and Guan, YingHua and Chen, Xiguang and Liu, Ya},
title = {Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy},
journal = {Nanoscale},
year = {2023},
doi = {10.1039/d2nr07071e}
}
EUVIMED